Sign in Register

Drug class

Angiotensin II Receptor Antagonists (ARBs)

Angiotensin II receptor antagonists, commonly known as angiotensin receptor blockers (ARBs), are a class of cardiovascular medications that selectively block the binding of angiotensin II to angiotensin II type 1 (AT1) receptors. Read more about Angiotensin II Receptor Antagonists (ARBs)

281 drugs in this class 82 manufacturers

Advertisement

Related classes & indications

Calcium Channel BlockersCardiovascular & renal · 344 prescription drugs Antihyperlipidemics HMGCo-A Reductase Inhibitors (Statins)Cardiovascular & renal · 194 prescription drugs HypertensionTop indication · 1,834 prescription drugs

Drugs in Angiotensin II Receptor Antagonists (ARBs)

Showing 199–207 of 281 drugs

TELMISARTAN

ANGIOTENSIN II RECEPTOR ANTAGONISTS (ARBS) · HYPERTENSION ·+2
LIFESTAR PHARMA

LOSARTAN POTASSIUM

ANGIOTENSIN II RECEPTOR ANTAGONISTS (ARBS) · DIABETIC NEPHROPATHY ·+2
DENTON PHARMA I

LOSARTAN POTASSIUM

ANGIOTENSIN II RECEPTOR ANTAGONISTS (ARBS) · DIABETIC NEPHROPATHY ·+2
APHENA PHARMA S

LOSARTAN POTASSIUM

ANGIOTENSIN II RECEPTOR ANTAGONISTS (ARBS) · DIABETIC NEPHROPATHY ·+2
NOVADOZ PHARMAC

TELMISARTAN

ANGIOTENSIN II RECEPTOR ANTAGONISTS (ARBS) · HYPERTENSION ·+2
MODAVAR PHARMAC
Filter & compare in the drug finder → Opens the drug finder with Angiotensin II Receptor Antagonists (ARBs) preselected. Add indication or manufacturer filters there.

About Angiotensin II Receptor Antagonists (ARBs).

Angiotensin II receptor antagonists, commonly known as angiotensin receptor blockers (ARBs), are a class of cardiovascular medications that selectively block the binding of angiotensin II to angiotensin II type 1 (AT1) receptors.

By preventing the downstream vasoconstrictive and aldosterone-secreting actions of the renin-angiotensin-aldosterone system, these agents promote vasodilation, enhance sodium and water excretion, and reduce vascular resistance.

Clinically, ARBs are widely prescribed as primary therapies for managing hypertension, treating heart failure, and slowing the progression of chronic kidney disease, particularly diabetic nephropathy.